Recall on Diabetes Medication Expanded
According to a new report by the FDA, Nostrum Laboratories has expanded its recall of Metformin HCI tablets. Metformin HCI extended-release tablets, generic Glucophage tablets, were found to have levels of N-Nitrosodimethylamine (NDMA.) NDMA is classified as a probable human…
Read More